SELECT TOP (1000) [Source] ,[Taxon] ,[LowValue] ,[HighValue] ,[LowPCile] ,[HighPCile] FROM [DB_A5D9F7_Lassesen].[dbo].[JasonH]

Gordonibacter urolithinfaciens Details: NCBI 1335613, high G+C gram-positive [species]

| CCUG 64261| DSM 27213| Gordonibacter sp. CEBAS 1/15P| Gordonibacter urolithinfaciens| Gordonibacter urolithinfaciens Selma et al. 2014| strain CEBAS 1/15P

  1. Infections: Anaerococcus species have been reported in various clinical infections, including bloodstream infections, intra-abdominal infections, wound infections, and infections in the female genital tract.

  2. Endocarditis: In some cases, Anaerococcus species have been implicated in infective endocarditis, particularly in individuals with underlying heart conditions.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Gordonibacter urolithinfaciens

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.4 19 901 0 732 214.6 144 263.8 19 901 9.1 %ile 81.8 %ile
thorne 100 11 1238 0 871 258.3 142 312.8 0 574 0 %ile 100 %ile
thryve 21.57 0 12 1 87 0 407 80.7 32 166.6 8 92 0 %ile 92 %ile
ubiome 9.76 0 0 21 1205 0 626 189 100 222.9 20 288 0 %ile 100 %ile

External Reference Ranges for Gordonibacter urolithinfaciens

Gordonibacter urolithinfaciens (NCBI 1335613) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 23.95 214.4 0.0024 0.0214
Statistic by Lab Source for Gordonibacter urolithinfaciens
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
CerbaLab 100 %   0.039 %  0.045 % 3.0 3
custom 1.695 %   0.002 %  % 1.0 59
es-xenogene 3.448 %   0.016 %  % 1.0 29
SequentiaBiotech 11.111 %   0.015 %  0.003 % 4.0 36
Thorne 84.091 %   0.016 %  0.025 % 74.0 88
Thryve 24.801 %   0.008 %  0.014 % 343.0 1383
uBiome 9.722 %   0.019 %  0.022 % 77.0 792

Symptoms Associated with Gordonibacter urolithinfaciens From Citizen Science Studies

Click on Impact for information if high or low levels are causing the impact

MagnitudeImpactSymptom

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Antibiotics, Antivirals etc florfenicol (antibiotic)s 1 Studies recorded. The consensus is Decreases📓, Click for details.
Drug or "Non-drug" florfenicol 1 Studies recorded. The consensus is Decreases📓, Click for details.
Food (excluding seasonings) Goji (berry,juice) 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) pomegranate 4 Studies recorded. The consensus is Increases👶📓, Click for details.
Food (excluding seasonings) pomegranate blossom tea 1 Studies recorded. The consensus is Increases📓, Click for details.
Miscellaneous, food additives, and other odd items smoking 1 Studies recorded. The consensus is Increases👶, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)